Assessment of novel technologies in healthcare - off-label use of drugs and the ethics of implementation and distribution of COVID-19 vaccines

Einstein (Sao Paulo). 2022 Jan 5:19:eED6840. doi: 10.31744/einstein_journal/2021ED6840.
[Article in English, Portuguese]
No abstract available

Publication types

  • Editorial

MeSH terms

  • COVID-19 Vaccines
  • COVID-19*
  • Delivery of Health Care
  • Humans
  • Off-Label Use
  • Pharmaceutical Preparations*
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines
  • Pharmaceutical Preparations